4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-035386
Senior Vice President and CFO sold 3,922 shares at $9.45 ($37,063)
From the SEC's structured data for this filing
Trades in this filing
STAAB THOMAS R II · Senior Vice President and CFO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-12-04 | Sale : show line 1 in the form | −3,922 | $9.45 | $37,063 | 133,461 | D |
| Open-market sales · 3,922 sh · avg $9.45 · $37,063 | ||||||
Loading xslF345X03/form4.xml…